Clinical Characteristics of 582 Patients with Uveal Melanoma in China.

To assess clinical characteristics, treatment and survival of patients with uveal melanoma in China.The retrospective study included all patients with malignant uveal melanoma who were consecutively examined in the study period from January 2005 and June 2015 in the Beijing Tongren hospital.The mean...

Full description

Bibliographic Details
Main Authors: Yue Ming Liu, Yang Li, Wen Bin Wei, Xiaolin Xu, Jost B Jonas
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4672905?pdf=render
id doaj-c1510b6c61b94581a3b3c613c084295c
record_format Article
spelling doaj-c1510b6c61b94581a3b3c613c084295c2020-11-25T02:13:36ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-011012e014456210.1371/journal.pone.0144562Clinical Characteristics of 582 Patients with Uveal Melanoma in China.Yue Ming LiuYang LiWen Bin WeiXiaolin XuJost B JonasTo assess clinical characteristics, treatment and survival of patients with uveal melanoma in China.The retrospective study included all patients with malignant uveal melanoma who were consecutively examined in the study period from January 2005 and June 2015 in the Beijing Tongren hospital.The mean age of the 582 patients (295(50.7%) women) was 44.6±12.6 years (range: 5-77 years). The tumors were located most often in the superior temporal region (in 117(21.5%) patients) and least common in the inferior region (in 31(5.7%) patients). In 548(94.2%) patients, the tumors were located in the choroid, in 33(5.7%) patients in the ciliary body, and in one (0.2%) patient in the iris. Treatment included episcleral brachytherapy (415(71.3%) patients), local tumor resection (48(8.2%) patients) and primary enucleation (119(20.4%) patients). In 53 individuals out of the 415 patients with primary brachytherapy, episcleral brachytherapy was followed by enucleation, due to an increasing tumor size or due to uncontrolled neovascular glaucoma. Median follow-up time was of 30 months (range: 1-124 months; mean: 34.8 ± 24.4 months). Overall survival rate at 5 and 10 years was of 92.7% and 85.1%. Younger age (P = 0.017), tumor location in the nasal meridian(P = 0.004), smaller tumor size (P<0.001), hemispheric tumor shape (P = 0.025), histological tumor cell type (spindle-cell type versus epitheloid cell type;P = 0.014), and type of treatment (episcleral brachytherapy versus local tumor resection and versus primary enucleation; P<0.001) were significantly associated with the overall survival in univariate analysis, while in multivariate analysis only smaller tumor size was significantly (P<0.001; RR: 4.75; 95% confidence interval: 2.11,10.7) associated with better overall survival.In this study on clinical characteristics of uveal melanoma of a larger group of patients from China, the onset age was considerably younger and survival rate better than in studies from Western countries. Tumor size was the most significant factor for survival.http://europepmc.org/articles/PMC4672905?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Yue Ming Liu
Yang Li
Wen Bin Wei
Xiaolin Xu
Jost B Jonas
spellingShingle Yue Ming Liu
Yang Li
Wen Bin Wei
Xiaolin Xu
Jost B Jonas
Clinical Characteristics of 582 Patients with Uveal Melanoma in China.
PLoS ONE
author_facet Yue Ming Liu
Yang Li
Wen Bin Wei
Xiaolin Xu
Jost B Jonas
author_sort Yue Ming Liu
title Clinical Characteristics of 582 Patients with Uveal Melanoma in China.
title_short Clinical Characteristics of 582 Patients with Uveal Melanoma in China.
title_full Clinical Characteristics of 582 Patients with Uveal Melanoma in China.
title_fullStr Clinical Characteristics of 582 Patients with Uveal Melanoma in China.
title_full_unstemmed Clinical Characteristics of 582 Patients with Uveal Melanoma in China.
title_sort clinical characteristics of 582 patients with uveal melanoma in china.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2015-01-01
description To assess clinical characteristics, treatment and survival of patients with uveal melanoma in China.The retrospective study included all patients with malignant uveal melanoma who were consecutively examined in the study period from January 2005 and June 2015 in the Beijing Tongren hospital.The mean age of the 582 patients (295(50.7%) women) was 44.6±12.6 years (range: 5-77 years). The tumors were located most often in the superior temporal region (in 117(21.5%) patients) and least common in the inferior region (in 31(5.7%) patients). In 548(94.2%) patients, the tumors were located in the choroid, in 33(5.7%) patients in the ciliary body, and in one (0.2%) patient in the iris. Treatment included episcleral brachytherapy (415(71.3%) patients), local tumor resection (48(8.2%) patients) and primary enucleation (119(20.4%) patients). In 53 individuals out of the 415 patients with primary brachytherapy, episcleral brachytherapy was followed by enucleation, due to an increasing tumor size or due to uncontrolled neovascular glaucoma. Median follow-up time was of 30 months (range: 1-124 months; mean: 34.8 ± 24.4 months). Overall survival rate at 5 and 10 years was of 92.7% and 85.1%. Younger age (P = 0.017), tumor location in the nasal meridian(P = 0.004), smaller tumor size (P<0.001), hemispheric tumor shape (P = 0.025), histological tumor cell type (spindle-cell type versus epitheloid cell type;P = 0.014), and type of treatment (episcleral brachytherapy versus local tumor resection and versus primary enucleation; P<0.001) were significantly associated with the overall survival in univariate analysis, while in multivariate analysis only smaller tumor size was significantly (P<0.001; RR: 4.75; 95% confidence interval: 2.11,10.7) associated with better overall survival.In this study on clinical characteristics of uveal melanoma of a larger group of patients from China, the onset age was considerably younger and survival rate better than in studies from Western countries. Tumor size was the most significant factor for survival.
url http://europepmc.org/articles/PMC4672905?pdf=render
work_keys_str_mv AT yuemingliu clinicalcharacteristicsof582patientswithuvealmelanomainchina
AT yangli clinicalcharacteristicsof582patientswithuvealmelanomainchina
AT wenbinwei clinicalcharacteristicsof582patientswithuvealmelanomainchina
AT xiaolinxu clinicalcharacteristicsof582patientswithuvealmelanomainchina
AT jostbjonas clinicalcharacteristicsof582patientswithuvealmelanomainchina
_version_ 1724904124999270400